Mitometin

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameMitometin
Drug Alias Namecarnitine palmitoyl transferase 1 inhibitor (2N Pharma)CPT1 inhibitor (2N Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectantsCarnitine palmitoyltransferase 1 inhibitors
TargetsCarnitine palmitoyltransferase 1
Therapy Area/IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies2N Pharma APS
China Registration ClassN/A

Develop Information

Active Companies2N Pharma APS
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A